[HTML][HTML] Whipple disease: a 15-year retrospective study on 36 patients with positive polymerase chain reaction for Tropheryma whipplei
FR Duss, K Jaton, P Vollenweider, N Troillet… - Clinical Microbiology and …, 2021 - Elsevier
Our institution has performed microbiological diagnosis of Tropheryma whipplei since 2001,
initially with a PCR targeting 16S rRNA before the development of a quantitative PCR in …
initially with a PCR targeting 16S rRNA before the development of a quantitative PCR in …
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report
FR Duss, C Garcia de la Mària… - Journal of …, 2019 - academic.oup.com
Objectives The best therapeutic approach for treating MRSA endocarditis remains unknown,
particularly in cases of high vancomycin MICs. We report here a case of daptomycin-non …
particularly in cases of high vancomycin MICs. We report here a case of daptomycin-non …
A 3-step therapeutic strategy for severe alveolar proteinosis
L Noirez, A Koutsokera, O Pantet, FR Duss… - The Annals of thoracic …, 2015 - Elsevier
Pulmonary alveolar proteinosis (PAP) is characterized by accumulation of lipoproteinaceous
material in the terminal airways. Whole lung lavage (WLL) remains the gold standard …
material in the terminal airways. Whole lung lavage (WLL) remains the gold standard …
HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis
MB Nunes, S Rotman, FR Duss… - BMJ Case Reports …, 2020 - casereports.bmj.com
Multicentric Castleman disease is a rare polyclonal lymphoproliferative disorder mainly
associated with two renal manifestations: thrombotic microangiopathy and amyloidosis …
associated with two renal manifestations: thrombotic microangiopathy and amyloidosis …
Rapid remission of Graves' hyperthyroidism without thionamides under immunosuppressive treatment for concomitant autoimmune hepatitis
GE Papadakis, F Lamine, H Chtioui, E Moschouri… - Thyroid, 2018 - liebertpub.com
Dear Editor: Common management options for Graves' disease (GD) include medical
treatment, radioactive iodine (RAI) ablation, or surgery. Thionamides (carbimazole …
treatment, radioactive iodine (RAI) ablation, or surgery. Thionamides (carbimazole …
Toxin-infections and toxin-related diseases due to Clostridia other than Clostridium difficile
FR Duss, C Voide - Revue Medicale Suisse, 2018 - europepmc.org
Clostridia cause severe diseases. Tetanus is rare in Switzerland because of vaccine
coverage and the application of guidelines for the management of contaminated wounds …
coverage and the application of guidelines for the management of contaminated wounds …
Myases from here and elsewhere: pseudo-furonculosis and Ignatzschineria larvae bacteremia
D Berthod, FR Duss, M Palazzuolo, M Eyer… - Revue Medicale …, 2020 - europepmc.org
Myiasis is an infestation by maggots. In humans, it predominates in regions with low socio-
economic development. We report on two cases of myiasis acquired during a tropical travel …
economic development. We report on two cases of myiasis acquired during a tropical travel …
Pneumococcal meningitis without pleocytosis in a patient infected with HIV-1
FR Duss, K Moulin, MM Bochatay, F Bally - AIDS, 2019 - journals.lww.com
3. Schroll JB, Moustgaard R, Gøtzsche PC. Dealing with substantial heterogeneity in
Cochrane reviews. Cross-sectional study. BMC Med Res Methodol 2011; 11: 22. 4. CDC …
Cochrane reviews. Cross-sectional study. BMC Med Res Methodol 2011; 11: 22. 4. CDC …
[HTML][HTML] Case report: HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis
MB Nunes, S Rotman, FR Duss, M Halfon - BMJ Case Reports, 2020 - ncbi.nlm.nih.gov
Multicentric Castleman disease is a rare polyclonal lymphoproliferative disorder mainly
associated with two renal manifestations: thrombotic microangiopathy and amyloidosis …
associated with two renal manifestations: thrombotic microangiopathy and amyloidosis …
An unusual cause of dysphagia
R Pfister, FR Duss, S Weitsch… - European Journal of …, 2018 - academic.oup.com
Figure 1: A healthy 79-year-old woman presented with cachexia, progressive dysphagia and
dyspnoea (New York Heart Association Class III) over 4 weeks.(A and B) Chest X-ray.(C) …
dyspnoea (New York Heart Association Class III) over 4 weeks.(A and B) Chest X-ray.(C) …